© 2026 Nanjing Finechem Holdings Co., Ltd,
All Right Reserved
Chemists have known about sulfonamides for generations, with their roots stretching back to the early years of antimicrobial research. Among these, 4-Amino-6-chloro-1,3-benzenedisulfonamide stands out for its utility and legacy. The journey began as researchers looked to fine-tune the basic sulfanilamide molecule, playing with substitutions that might enhance biological activity without ramping up the risks. The introduction of a chlorine atom along with dual sulfonamide groups helped create a molecule that brought more than just chemical novelty. This mix provided stability, new avenues for medicinal chemistry, and a foundation for further exploration, around the same era folks started taking seriously the standardization of pharmaceutical ingredients. It’s easy to overlook just how much trial and error happened in those early decades, where curiosity and necessity pushed science forward, sometimes inch by inch.
Ask anyone working in drug development or diagnostics, and they will likely have come across 4-Amino-6-chloro-1,3-benzenedisulfonamide, either in the lab or referenced in the literature. It’s not some blockbuster therapy, but it often plays a supporting role—sometimes anchoring screening protocols, sometimes serving as an intermediate, and sometimes helping in the synthesis of compounds with prized biological activity. This molecule’s value often comes down to its versatility in chemical transformations and the reliability of its functional groups for downstream modifications.
This compound presents as a pale solid, not much to look at, but its configuration deserves a second glance. The molecular structure centers a benzene ring with amino and chloro groups in precise positions, along with two sulfonamide arms. This design lets the molecule dissolve well in polar solvents, making it convenient for lab work. Chemical stability holds up unless exposed to extreme pH or relentless heat, so most labs handle it with basic measures. A small shift in functional groups can nudge its properties, making it both a good target and a handy building block.
Whether manufactured for laboratory research or as an active intermediate, purity often comes in at 98% or greater. High-performance liquid chromatography usually confirms the identity, but comparison to reference standards matters just as much. Warning labels draw attention to its sulfonamide backbone—especially because some individuals react to these chemicals. The industry moves toward keeping packaging as clear as possible, spelling out chemical identity, batch, and any trace contaminants from the production process. Regulatory bodies usually ask for tight controls on contaminants like heavy metals and residual solvents, and those requirements often reflect broader trends in keeping the supply chain clean.
Labs have finetuned a few different synthesis routes for this compound, though the best methods rely on tried-and-true organic reactions. Starting from chlorinated aromatic materials, chemists attach sulfonamide groups using carefully regulated temperatures and sulfonation reagents. Amination takes a bit of finesse, as keeping the amino group at the right position means juggling reaction conditions and purification steps. Dedicated teams have managed to improve these routes, trimming down steps, and working out bottlenecks that otherwise led to unnecessary waste or inconsistent yield. Waste management still poses a challenge, especially with byproduct formation during sulfonation, but techniques to recycle solvents and neutralize effluents help keep the process within manageable environmental limits.
From a bench chemist's perspective, the compound’s most attractive features are its modifiable sites. Chemists can tweak the amino or chloro group to generate whole families of analogs for research, and the twin sulfonamide arms provide multiple points for coupling reactions or protective group strategies. In medicinal chemistry, analogs incorporating minor tweaks to this backbone sometimes show up in screens for enzyme inhibition, antibacterial activity, or even as starting materials for colorimetric assays. Substitution reactions, amidation, and reductive transformations all see regular use, making it an old reliable in synthesis pipelines. Newer research often revisits these classic modifications, searching for altered potency or improved selectivity against stubborn biological targets.
The official IUPAC name carries as much weight in regulatory paperwork as in academic publishing. Around the lab, though, the compound might pick up shorthand like “4-amino-6-chloro benzenedisulfonamide” or variations tied to manufacturer catalogues. Researchers juggling multiple sulfonamide derivatives appreciate consistency in naming, since confusion often leads to wasted time or even invalid experiments. In chemical suppliers' catalogues, the synonyms and CAS number help cut through ambiguity, especially for those ordering globally or cross-referencing with patents and clinical literature.
Handling sulfonamide compounds means taking health precautions seriously. Even if this chemical isn’t as notorious as some stronger irritants, direct contact with skin or inhalation risks shouldn’t be overlooked. Labs adopt standard protective gear—gloves, goggles, lab coats—and rely on proper fume hoods during manipulations prone to dust or vapor release. As with all sulfonamide derivatives, individuals with a history of sensitivity watch out for allergic reactions, which can range from mild rashes to more severe effects. Cleanroom protocols focus on keeping contamination out, especially in pharmaceutical environments, and there’s a real awareness that even trace contamination can sabotage research outcomes or regulatory compliance. Waste disposal feeds into broader conversations on environmental stewardship: collecting all solid and liquid residues, labeling them, and transferring for specialized treatment outside the research facility.
There’s a solid track record for 4-Amino-6-chloro-1,3-benzenedisulfonamide in medicinal and analytical labs. Medicinal chemistry sees it as an intermediate for anti-infective agents, and regular screening protocols tap its chemical reactivity. Sometimes it crops up in diagnostic assay development, where its structure helps tune selectivity or sensitivity—turning a bench-top curiosity into a tool for biomedical innovation. Environmental chemistry also finds uses here, mostly as a calibration standard or probe in pollutant identification work. The demand isn’t on the scale of commodity chemicals, but every working research library seems to keep a small stash for both predictable projects and spur-of-the-moment troubleshooting.
In the world of R&D, incremental advances often make the biggest difference. For this compound, current efforts look at two main fronts: improving synthetic efficiency and exploring new therapeutic applications. Some chemists hunt for milder or greener routes to key intermediates, dropping hazardous reagents or swapping them for more sustainable options. On the biological side, the structure serves as a launching pad for next-generation drug scaffolds, especially as researchers try to dodge antibiotic resistance with novel sulfonamide analogs. The compound’s robust electrochemical properties even invite experiments in materials science, where new derivatives test out as potential sensors or electronic modifiers. Interdisciplinary teams prove especially productive, drawing from organic, analytical, and computational backgrounds to unravel new uses.
Most risk assessments paint sulfonamide derivatives as generally manageable in controlled environments, but deeper dives matter. Some subpopulations carry genetic markers or health conditions that crank up sensitivity to sulfonamides. Lab animals exposed to these compounds over extended periods sometimes develop mild organ toxicity, especially at doses far above therapeutic recommendations. Regulatory guidelines encourage keeping exposures to a minimum, and published toxicological studies reference both acute and chronic measures. Researchers still carry out detailed in vitro and in vivo studies for newly-modified analogs, with special attention to mutagenic or teratogenic potential. That diligence keeps doors open for the compound’s further development without sidelining safety.
Looking ahead, the humble profile of 4-Amino-6-chloro-1,3-benzenedisulfonamide actually sets up plenty of room for new applications. As more pressure builds on the pharmaceutical sector to innovate past resistance trends, classic structures like this one will keep seeing tweaks aimed at unlocking overlooked biological activity. Green chemistry initiatives guarantee more attention to process efficiency, solvent choice, and waste minimization during synthesis. Analytical labs lean into its established chemical responses, tuning protocols for environmental monitoring and medical diagnostics alike. No one expects a sudden revolution, but as research communities double down on reliability and adaptability, this old standby will keep finding its way onto lab benches and into new applications. The need for chemical and biological understanding grows larger each year, and tools with a strong history have a way of proving themselves useful long after headline trends have come and gone.
Most people haven't heard much about 4-Amino-6-chloro-1,3-benzenedisulfonamide unless they're working in chemistry or pharmaceuticals. This compound matters more than its complicated name suggests. Scientists know it as a key building block in making some medications—especially those that fall under the category of sulfonamides, a group with a long track record in treating bacterial infections. My background in science research has shown me just how crucial these precursor chemicals are—they allow drug developers to tweak and refine effects, turning a raw chemical into something with life-changing potential.
The most direct use for 4-Amino-6-chloro-1,3-benzenedisulfonamide rests in drug synthesis. Chemists rely on it to make certain types of sulfa drugs, which were once front-line treatments before more modern antibiotics arrived. The structure of this compound makes it a strong candidate for modifications, allowing researchers to attach different groups and adjust how the medicine interacts with bacteria. The discovery and usage of sulfonamide drugs marked a turning point during the 20th century; they cut mortality from infections and gave people the first taste of reliable antibacterial therapy.
Beyond established uses in antibiotics, this compound opens doors for experimentation. Lab teams look for new ways to tackle drug resistance. They choose molecules like 4-Amino-6-chloro-1,3-benzenedisulfonamide because the two sulfonamide groups and the chlorine atom make for a chemically versatile template. This means chemists can engineer new drug candidates, not just for infections but sometimes even for other illnesses where sulfonamide derivatives show promise—such as diabetes and inflammatory conditions. Each time a resistant bacterium shrugs off a favorite antibiotic, researchers turn back to the lab, starting again with time-tested scaffolds like this one.
Having worked alongside people in both research and chemical safety, I’ve learned that handling chemicals like 4-Amino-6-chloro-1,3-benzenedisulfonamide deserves attention. It’s not a compound you want floating around households. Factories and labs make sure proper storage happens, along with training workers on safe handling. This chemical isn’t hazardous for end users of medicine, but in its raw form, it can irritate and should never touch skin or eyes. Regulators in different countries keep an eye on substances like this, watching not only for safety lapses but also illegal diversion to non-medical uses.
The world faces frequent reminders about the threat posed by antibiotic resistance. Old drugs stop working, bacteria become more stubborn, and hospitals scramble for solutions. With compounds like 4-Amino-6-chloro-1,3-benzenedisulfonamide, there’s a toolkit for drug discovery that isn’t just resting on old breakthroughs. My time following pharmaceutical innovation makes it obvious: progress depends on both smart chemistry and real-world controls. Supporting better funding for research, maintaining strict safety standards at every step, and sharing new findings globally all help. Anyone who has watched a loved one bounce back from a nasty infection knows that a safer, more reliable medicine isn’t just science—it’s personal.
4-Amino-6-chloro-1,3-benzenedisulfonamide carries the chemical formula C6H8ClN3O4S2. We’re looking at a compound with a backbone of benzene, two sulfonamide groups, an amino group, and a chlorine tag for good measure. It weighs in at about 285.73 grams per mole. This figure isn’t just trivia for chemists. Lab workers and manufacturers depend on precise molecular weights for dosing, reagent prep, and safety protocols. Getting the math wrong could throw off batch consistency in pharmaceuticals, waste resources in the chemical industry, or even cause harm to researchers and patients.
Any lab that deals with sulfonamides takes accuracy seriously. These compounds help form the backbone of antibiotics and some popular diuretics. Tweaking a chemical formula or misreporting molecular weight can ruin weeks of careful experiments. Imagine going through countless trials only to learn a slip with the numbers sabotaged the findings—all that time and money poured down the drain. In research, missing the target formula even by a single atom might mean a breakthrough treatment gets delayed for months. Lives can hang in the balance, especially for teams working on antimicrobials to challenge resistant strains in clinical settings.
Handling these compounds in a university lab hammered this lesson home. One time, a chemical supplier mislabeled the molecular weight on a batch of benzenedisulfonamide. The mix-up nearly derailed the synthesis of enzyme inhibitors. Layers of lab safety depend on knowing what’s in your flask. Some researchers double-check labels, others run NMR, but the best practice always involves cross-referencing the chemical formula. This becomes second nature to anyone who’s seen the fallout of a simple oversight—unexpected melting points, failed purifications, or ruined spectra. You grow a genuine respect for the discipline required in bench chemistry.
It’s easy to overlook the building blocks behind the big discoveries in medicine. Yet, compounds like 4-Amino-6-chloro-1,3-benzenedisulfonamide underpin real-world advances. Hospitals rely on precise formulations to treat bacterial and metabolic diseases. Drug developers use defined weights and formulas to pass regulatory hurdles and produce repeatable, effective therapies. Teachers use these examples to show students that chemistry doesn’t end at the blackboard—the lessons leak into every shelf of a pharmacy.
On a day-to-day basis, chemists, pharmacists, and quality control teams use rigorous detail. Checking that C6H8ClN3O4S2 clocks in at 285.73 g/mol is more than a classroom exercise. Fact-checking creates safer environments and better products. That level of care reduces waste, limits risk, and speeds up the road from discovery to treatment. Information might look dry on the page, but it drives practical solutions every single day.
Teams sometimes lean too hard on pre-filled labels or outdated reference tables. Updating digital resources, running routine spot checks, and promoting a double-check culture all help. It takes more than a single person; working together, sharing confirmed data, and holding each other accountable reduces mistakes. Transparency builds better science and trust. Accurate labels keep the wheels turning so researchers, students, and patients can count on the information being right every step of the way.
Few people outside chemical labs recognize the name 4-Amino-6-chloro-1,3-benzenedisulfonamide. This compound pops up in research, industrial applications, and sometimes, efforts to build something new in pharmaceuticals. Its unusual name masks a bigger question nagging at anyone handling jars of reagents: is it safe, or hiding health risks nobody wants in their workspace?
My time studying and working in labs has taught me not to take chemicals at face value. Each substance comes with its quirks. Sulfonamides like this one belong to a family connected with medicines but they also pose their own set of hazards. Eye and skin irritation stands out on most safety sheets. That’s not just paranoia; I’ve seen colleagues get rashes they blamed on rough gloves, only to trace the cause to a tiny spill.
Acute toxicity from compounds like these usually means accidentally breathing dust or fumes, swallowing a bit by accident, or getting some on open skin. Sometimes people notice right away—coughing, nausea, itchy patches. But not every case is obvious or severe. Health and safety databases describe acute oral or dermal toxicity for benzenedisulfonamides, although many gaps remain in public research. The chlorine atom raises an eyebrow too, since halogenated organic compounds sometimes linger longer in the body and environment.
Chemical companies warn about contact but often stay quiet about the details. It’s hard to find up-to-date data about long-term effects. Workers ask about cancer risk and often find no clear answer, just that some sulfonamides link to allergic reactions or immune effects. I’ve seen lab mates suffer headaches and coughs nobody could pin down until stricter containment improved things. Reading between the lines, it feels smarter to treat this compound with the same respect as any laboratory irritant: gloves on, vents running, no food nearby, scrub up after handling.
Let’s not forget storage and disposal. The same chlorine atom that complicates medical chemistry can mess up aquatic systems if waste goes down the sink. Sulfonamides in the water supply persist, and microbial communities can suffer, especially if these chemicals carry through waste treatment systems. As more laboratories consider environmental footprints, these details start guiding policy—not just health inside the building, but outside it as well.
The most important safeguard starts with information. Don’t trust a blank or vague safety sheet; look for toxicological reports, environmental warnings, and real-world injury data. I’ve learned to simplify safety: gloves, goggles, strong ventilation, and closed containers. If exposure happens, early washing and medical checks save headaches later, literally and figuratively.
On a bigger scale, institutions should push suppliers for detailed hazard statements and demand updates if new research reveals hidden dangers. Waste collection shouldn’t rely on the “low-volume, low-risk” excuse that too many labs use out of convenience.
Mistakes often follow forgotten safety measures. Questioning the risks of each chemical can sound repetitive, but there's value in stubborn diligence. Building habits around chemicals like 4-Amino-6-chloro-1,3-benzenedisulfonamide reduces harm to both workers and neighbors, especially as new data fills in the blanks the industry still leaves open.
Care and questioning work best for unknown or under-studied chemicals. Treating all compounds with practiced respect—not just the scary, famous ones—keeps the surprises down and confidence up, both in the lab and in the waste stream heading far beyond our walls.
Shelf chemistry rarely forgives shortcuts. I learned this early sorting through bins in a university lab—small decisions around storage keep chemicals stable and people safe. 4-Amino-6-chloro-1,3-benzenedisulfonamide can’t just get tossed on a shelf with a torn label. One careless move, and you face lost dollars or dangerous reactions. Safety never feels dramatic on a calm day, but a misplaced jar or a degraded powder reminds everyone that paying attention, day in and day out, matters more than we think.
This compound, known for its uses in pharmaceuticals and research, breaks down with moisture, heat, and light. It doesn’t explode, but slow breakdown quietly erodes potency and purity. This means that slurry of molecules, after enough sloppy storage, no longer works the way scientists expect. Poor storage also opens a door to impurities—think accidental mix-ins from the air or leeching from plastic. Most labs want to avoid extra variables, and degraded batches frustrate both researchers and managers.
From experience and safety data, the best way to keep 4-Amino-6-chloro-1,3-benzenedisulfonamide stable looks pretty straightforward. It requires a tightly closed container, protected from humidity, and kept at room temperature. A dry, dark spot stays trusted—light breaks down some aromatic rings, and heat speeds up reactions. Keeping the bottle well labeled and out of sunlight isn’t fancy, but it works.
Desiccators become essential in humid climates. Even in well-ventilated rooms, tropical air can turn a powder to mush. I spent weeks in Indonesia with chemicals stored direct in glass, and the local humidity crept in fast. That batch needed replacement sooner than expected. Labs in temperate zones get away with sealed cabinets, though a desiccant pouch never hurts for insurance.
Using glass bottles over plastics minimizes leaching. In my own work, old plastic jars sometimes left an odor in fine powders, or added a film on the side. This compound stays more reliable in pyrex or amber glass. And while some chemicals seem indestructible, 4-Amino-6-chloro-1,3-benzenedisulfonamide shows a slow but steady drift in quality if stored next to strong acids or oxidizers—those kinds of neighbors turn safe powders hazardous after a spill or a fume leak. Segregated shelving grew from hard experience, not just protocols.
Missed labels cause confusion, not just for yourself, but for the next shift or even someone years later. I’ve had to test mystery jars more than once, eating up time and budget best spent elsewhere. Lot numbers and receive dates should always go on containers. Backup inventory on a spreadsheet makes tracking who used what a regular habit.
Good habits start with training. I’ve watched new lab techs wing it, only for a supervisor to catch mistakes too late. An upfront walkthrough with actual samples helps the lesson stick. Leadership in a workplace that treats proper storage as central gets better results—that means providing the right cabinets, air conditioning, and even signage. Too often long lists of guidelines gather dust. Routine checks with a clipboard and a fresh set of eyes stop problems early. Leaving storage up to memory or ‘how things usually go’ leads to surprises down the road, especially if staff changes hands.
At the end of the day, there’s no real shortcut. The simple, regular steps—dry storage, tight seals, proper labeling, and segregation—keep both chemicals and people safe. It’s not glamorous work, but slow attention to these details prevents the emergencies no one wants to explain.
If you’ve spent time in a lab or worked with specialty chemicals, you notice quickly that purity is a make-or-break detail. With 4-Amino-6-chloro-1,3-benzenedisulfonamide, the purity figure lands around 98% or higher in reputable supply chains. This purity isn’t a technical boast—it’s a necessity. In research, medicinal chemistry, or analytical laboratories, small contaminants can send experiments sideways. My experience working with compounds almost always led me to sweat over purity certificates before trusting a new reagent. For something like this benzenedisulfonamide, impurities can cast doubt on the reliability of toxicity studies, pharma projects, or even environmental testing.
Lab teams don’t just look for a high number on the label; they also want transparency on exactly what “the rest” of the sample includes. Trustworthy suppliers list everything from potential chloride ions to residual solvents, backed with a recent certificate of analysis. It’s common to find High-Performance Liquid Chromatography (HPLC) data or impurity profiles attached because mistakes in synthesis show up later if folks skip this check. If you’ve ever tried troubleshooting a failed assay, you know that a spike in unknown impurities turns the job into a headache.
Packaging sizes for 4-Amino-6-chloro-1,3-benzenedisulfonamide come in a range that reflects the different environments it enters. Typically, labs use bottles as small as 10 or 25 grams, almost like an insurance policy against degradation or cross-contamination. This size is also practical for cost—why spend on excess when the shelf life of sulfonamides hovers in the moderate range? For scaling up in pilot plants or pharmaceutical manufacturing, you see kilogram-sized plastic or steel drums, sometimes lined with a foil bag. Moisture and light protection matter here, so packaging that prevents clumping or breakdown means you lose less to spoilage.
I remember early in my career ordering bulk chemicals only to find out that poor packaging transformed half the shipment into a rock-solid chunk—impossible to weigh or dissolve accurately. Industry experience taught me that reliable suppliers care about the details of sealing, labeling, and traceability. They provide tamper-evident closures and hazard labeling that matches strict regulatory requirements. Large volumes might arrive with safety documentation, lot traceability, and storage instructions tucked into the shipment, not as an afterthought but as part of responsible stewardship.
Because 4-Amino-6-chloro-1,3-benzenedisulfonamide sometimes lands in applications connected to sensitive biological or pharmaceutical research, there’s no shortcut around transparency. Look for batch consistency and standardized purity checks from independent labs where possible. It helps to develop relationships with suppliers who answer questions quickly and offer full documentation on both purity and packaging.
The core issues—purity and packaging—aren’t add-ons in chemical procurement. They define whether research and industrial teams trust a compound across multiple projects. Simple steps like comparing certificates of analysis, confirming proper seals, and keeping an eye out for comprehensive labeling make all the difference. In my own work, striking a balance between getting “enough” material and not overspending on excess inventory became a constant task. Long-term project budgets, compliance needs, and lab safety all depend on these up-front choices. Those who cut corners on purity or packaging end up paying for it in lost productivity and missed discoveries.
| Names | |
| Preferred IUPAC name | 4-amino-6-chlorobenzene-1,3-disulfonamide |
| Other names |
Dichloramine T 6-Chloro-4-aminobenzene-1,3-disulfonamide 6-Chloro-4-aminobenzene-1,3-disulfonic acid amide Chloramin T 4-Amino-6-chlorobenzene-1,3-disulfonamide |
| Pronunciation | /ˈfɔːr əˈmiːnoʊ sɪks ˈklɔːroʊ wʌn θriː bɛnˈziːn daɪˌsʌlfəˌnæmaɪd/ |
| Identifiers | |
| CAS Number | 121-30-2 |
| 3D model (JSmol) | `3D Model (JSmol) string` for **4-Amino-6-chloro-1,3-benzenedisulfonamide**: ``` CC1=C(C=C(C(=C1S(=O)(=O)N)S(=O)(=O)N)N)Cl ``` *(This is the SMILES string, typically used for JSmol or 3D molecular visualization tools.)* |
| Beilstein Reference | 1766447 |
| ChEBI | CHEBI:2823 |
| ChEMBL | CHEMBL554 |
| ChemSpider | 21106407 |
| DrugBank | DB00864 |
| ECHA InfoCard | ECHA InfoCard: 100.018.400 |
| EC Number | 3.5.4.19 |
| Gmelin Reference | 1680837 |
| KEGG | C07443 |
| MeSH | D020123 |
| PubChem CID | 68521 |
| RTECS number | DG5900000 |
| UNII | 7R6H6WH6LU |
| UN number | 2811 |
| CompTox Dashboard (EPA) | DTXSID8020400 |
| Properties | |
| Chemical formula | C6H8ClN3O4S2 |
| Molar mass | 298.73 g/mol |
| Appearance | White to off-white solid |
| Odor | Odorless |
| Density | 1.8 g/cm³ |
| Solubility in water | Slightly soluble |
| log P | -0.28 |
| Vapor pressure | 1.82E-10 mmHg at 25°C |
| Acidity (pKa) | 7.4 |
| Basicity (pKb) | 7.85 |
| Magnetic susceptibility (χ) | -0.72e-6 cm³/mol |
| Refractive index (nD) | 1.720 |
| Dipole moment | 3.5352 Debye |
| Thermochemistry | |
| Std molar entropy (S⦵298) | 322.9 J·mol⁻¹·K⁻¹ |
| Std enthalpy of combustion (ΔcH⦵298) | -1454 kJ·mol⁻¹ |
| Pharmacology | |
| ATC code | S01CA02 |
| Hazards | |
| Main hazards | Harmful if swallowed. Causes serious eye irritation. Causes skin irritation. May cause respiratory irritation. |
| GHS labelling | GHS07; GHS08; Warning; H302; H373; P264; P270; P301+P312; P314 |
| Pictograms | GHS07 |
| Signal word | Warning |
| Hazard statements | H302, H319, H335 |
| Precautionary statements | P261, P264, P271, P272, P273, P280, P302+P352, P305+P351+P338, P312, P321, P332+P313, P337+P313, P362+P364, P501 |
| NFPA 704 (fire diamond) | 2-1-0 |
| Flash point | > 284.2 °C |
| Lethal dose or concentration | LD50 Oral Rat 5200 mg/kg |
| LD50 (median dose) | LD50 (median dose): Oral rat LD50 = 1210 mg/kg |
| NIOSH | GN7700000 |
| PEL (Permissible) | Not established |
| REL (Recommended) | 50 mg |
| Related compounds | |
| Related compounds |
Chlorothiazide Hydrochlorothiazide Benzthiazide Cyclothiazide Metolazone |
